© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 04, 2021
Because several pharmaceutical companies pulled back from the federal 340B program last fall, many patients with diabetes are now seeing skyrocketing insulin prices, according to Anne Webster, NP, with UnityPoint Health.
May 03, 2021
The approval of dapagliflozin is the most significant advancement in the treatment of chronic kidney disease in more than 20 years, according to a press release.
A heart rhythm disorder, atrial fibrillation occurs at least twice as frequently in patients with diabetes as those without.
April 28, 2021
This data could offer additional insights into how the pandemic may be impacting the nation's children, according to the study authors.
April 27, 2021
A greater understanding of obesity and its impact on cardiovascular health highlights abdominal obesity, sometimes referred to as visceral adipose tissue (VAT), as a cardiovascular disease risk marker.
April 23, 2021
The study highlights a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.
April 21, 2021
Patients with COVID-19 and obesity were more likely to require oxygen and had a 73% greater change of requiring invasive mechanical ventilation.
April 20, 2021
Pharmacists can sort through options to reduce confusion for patients and prescribers
April 19, 2021
This information will help them understand the patient medical needs during fasting and make proper adjustments in the treatment regimen where necessary.
Long-term societal and economic impacts of the COVID-19 pandemic have promoted urgent responses in many sectors, which could lead to real-world efforts to improve prevention of chronic health conditions.